BioNote Statistics

Total Valuation

BioNote has a market cap or net worth of KRW 459.17 billion. The enterprise value is 57.68 billion.

Market Cap	459.17B
Enterprise Value	57.68B

Important Dates

The next estimated earnings date is Thursday, May 15, 2025.

Earnings Date	May 15, 2025
Ex-Dividend Date	Mar 28, 2025

Share Statistics

BioNote has 101.36 million shares outstanding. The number of shares has decreased by -0.08% in one year.

Current Share Class	n/a
Shares Outstanding	101.36M
Shares Change (YoY)	-0.08%
Shares Change (QoQ)	-0.29%
Owned by Insiders (%)	54.93%
Owned by Institutions (%)	0.29%
Float	17.71M

Valuation Ratios

The trailing PE ratio is 8.36.

PE Ratio	8.36
Forward PE	n/a
PS Ratio	4.47
PB Ratio	0.28
P/TBV Ratio	0.28
P/FCF Ratio	9.68
P/OCF Ratio	7.93
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 1.47, with an EV/FCF ratio of 1.22.

EV / Earnings	1.04
EV / Sales	0.56
EV / EBITDA	1.47
EV / EBIT	1.85
EV / FCF	1.22

Financial Position

The company has a current ratio of 19.69, with a Debt / Equity ratio of 0.00.

Current Ratio	19.69
Quick Ratio	18.20
Debt / Equity	0.00
Debt / EBITDA	0.19
Debt / FCF	0.08
Interest Coverage	52.31

Financial Efficiency

Return on equity (ROE) is 3.46% and return on invested capital (ROIC) is 0.48%.

Return on Equity (ROE)	3.46%
Return on Assets (ROA)	0.46%
Return on Invested Capital (ROIC)	0.48%
Return on Capital Employed (ROCE)	0.73%
Revenue Per Employee	344.90M
Profits Per Employee	185.44M
Employee Count	298
Asset Turnover	0.06
Inventory Turnover	1.86

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +13.66% in the last 52 weeks. The beta is 1.04, so BioNote's price volatility has been similar to the market average.

Beta (5Y)	1.04
52-Week Price Change	+13.66%
50-Day Moving Average	4,720.80
200-Day Moving Average	4,641.83
Relative Strength Index (RSI)	44.71
Average Volume (20 Days)	55,681

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, BioNote had revenue of KRW 102.78 billion and earned 55.26 billion in profits. Earnings per share was 542.00.

Revenue	102.78B
Gross Profit	50.97B
Operating Income	12.22B
Pretax Income	73.33B
Net Income	55.26B
EBITDA	20.40B
EBIT	12.22B
Earnings Per Share (EPS)	542.00

Full Income Statement

Balance Sheet

The company has 405.42 billion in cash and 3.93 billion in debt, giving a net cash position of 401.49 billion or 3,960.93 per share.

Cash & Cash Equivalents	405.42B
Total Debt	3.93B
Net Cash	401.49B
Net Cash Per Share	3,960.93
Equity (Book Value)	1.64T
Book Value Per Share	16,137.75
Working Capital	442.04B

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 57.92 billion and capital expenditures -10.46 billion, giving a free cash flow of 47.45 billion.

Operating Cash Flow	57.92B
Capital Expenditures	-10.46B
Free Cash Flow	47.45B
FCF Per Share	468.17

Full Cash Flow Statement

Margins

Gross margin is 49.59%, with operating and profit margins of 11.89% and 53.77%.

Gross Margin	49.59%
Operating Margin	11.89%
Pretax Margin	71.34%
Profit Margin	53.77%
EBITDA Margin	19.85%
EBIT Margin	11.89%
FCF Margin	46.17%

Dividends & Yields

This stock pays an annual dividend of 200.00, which amounts to a dividend yield of 4.41%.

Dividend Per Share	200.00
Dividend Yield	4.41%
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	36.94%
Buyback Yield	0.08%
Shareholder Yield	4.49%
Earnings Yield	12.04%
FCF Yield	10.33%

Dividend Details

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

BioNote has an Altman Z-Score of 5.99.

Altman Z-Score	5.99
Piotroski F-Score	n/a